These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19748118)

  • 21. Decreased gene expression of neuropeptide Y and its receptors in hippocampal regions during ethanol withdrawal in rats.
    Olling JD; Ulrichsen J; Haugbøl S; Glenthøj B; Hemmingsen R; Woldbye DP
    Neurosci Lett; 2007 Sep; 424(3):160-4. PubMed ID: 17723274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NPY signalling pathway in bone homeostasis: Y1 receptor as a potential drug target.
    Sousa DM; Herzog H; Lamghari M
    Curr Drug Targets; 2009 Jan; 10(1):9-19. PubMed ID: 19149531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function.
    Gehlert DR; Shaw JL
    Peptides; 2007 Feb; 28(2):241-9. PubMed ID: 17208335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses.
    Ammar DA; Hughes BA; Thompson DA
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1870-8. PubMed ID: 9727410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor.
    Naveilhan P; Hassani H; Canals JM; Ekstrand AJ; Larefalk A; Chhajlani V; Arenas E; Gedda K; Svensson L; Thoren P; Ernfors P
    Nat Med; 1999 Oct; 5(10):1188-93. PubMed ID: 10502824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoblastic Actions of the Neuropeptide Y System to Regulate Bone and Energy Homeostasis.
    Horsnell H; Baldock PA
    Curr Osteoporos Rep; 2016 Feb; 14(1):26-31. PubMed ID: 26872458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular evolution of NPY receptor subtypes.
    Larhammar D; Salaneck E
    Neuropeptides; 2004 Aug; 38(4):141-51. PubMed ID: 15337367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression cloning of a human brain neuropeptide Y Y2 receptor.
    Gehlert DR; Beavers LS; Johnson D; Gackenheimer SL; Schober DA; Gadski RA
    Mol Pharmacol; 1996 Feb; 49(2):224-8. PubMed ID: 8632753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between NPY and CRF in the amygdala to regulate emotionality.
    Sajdyk TJ; Shekhar A; Gehlert DR
    Neuropeptides; 2004 Aug; 38(4):225-34. PubMed ID: 15337374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropeptide Y modulates steroid production of human adrenal H295R cells through Y1 receptors.
    Kempná P; Körner M; Waser B; Hofer G; Nuoffer JM; Reubi JC; Flück CE
    Mol Cell Endocrinol; 2010 Jan; 314(1):101-9. PubMed ID: 19699258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Y2 and Y4 receptor signalling attenuates the skeletal response of central NPY.
    Lee NJ; Allison S; Enriquez RF; Sainsbury A; Herzog H; Baldock PA
    J Mol Neurosci; 2011 Feb; 43(2):123-31. PubMed ID: 20635164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
    Spinazzi R; Andreis PG; Nussdorfer GG
    Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture.
    Abounader R; Elhusseiny A; Cohen Z; Olivier A; Stanimirovic D; Quirion R; Hamel E
    J Cereb Blood Flow Metab; 1999 Feb; 19(2):155-63. PubMed ID: 10027771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropeptide Y2 receptors as drug targets for the central regulation of body weight.
    Félétou M; Levens NR
    Curr Opin Investig Drugs; 2005 Oct; 6(10):1002-11. PubMed ID: 16259221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
    Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
    Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral-specific y2 receptor knockdown protects mice from high-fat diet-induced obesity.
    Shi YC; Lin S; Castillo L; Aljanova A; Enriquez RF; Nguyen AD; Baldock PA; Zhang L; Bijker MS; Macia L; Yulyaningsih E; Zhang H; Lau J; Sainsbury A; Herzog H
    Obesity (Silver Spring); 2011 Nov; 19(11):2137-48. PubMed ID: 21546930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference of NPY and its receptor gene expressions between obesity and obesity-resistant rats in response to high-fat diet.
    Wang C; Yang N; Wu S; Liu L; Sun X; Nie S
    Horm Metab Res; 2007 Apr; 39(4):262-7. PubMed ID: 17447163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
    Umeda T; Kanatani A; Iwaasa H
    Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.
    Cabrele C; Beck-Sickinger AG
    J Pept Sci; 2000 Mar; 6(3):97-122. PubMed ID: 10759209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.